AWH: Aspira Women's Health Inc. Stock

by  •  • Comments Off on AWH: Aspira Women's Health Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 11.97
Enterprise Value ($M) 11.56
Book Value ($M) -2.52
Book Value / Share -0.16
Price / Book -4.75
NCAV ($M) -3.17
NCAV / Share -0.20
Price / NCAV -3.78

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.71
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.70
Current Ratio 0.75

Balance Sheet (mrq) ($M)
Current Assets 4.11
Assets 4.76
Liabilities 7.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Dilutive Effect Of Stock Options n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G Armistice Capital, Llc 7.76
07-11 13D/A Schuler Jack W 14.00 0.34
04-08 13G/A Schultz Eric Adam 4.41 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-01 10-K Delaware (State or Other Jurisdiction of Incorporation or Organization) 12117 Bee Caves Road, Building III, Suite 100 Austin, Texas (Address of Principal Executive Offices) DOCUMENTS INCORPORATED BY REFERENCE

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 15,474 82,888 18.67
2024-11-21 6,159 28,343 21.73
2024-11-20 26,477 50,229 52.71
2024-11-19 43,935 167,352 26.25
2024-11-18 2,459 53,146 4.63

(click for more detail)

Similar Companies
ATXI – Avenue Therapeutics, Inc. ATYR – aTyr Pharma, Inc.
AVTX – Avalo Therapeutics, Inc. AYTU – Aytu BioPharma, Inc.
BCDA – BioCardia, Inc.


Financial data and stock pages provided by
Fintel.io